Markers of androgen-independent progression of prostatic carcinoma

被引：0
作者：
Daliani, D [1 ]
Papandreou, CN [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
SEMINARS IN ONCOLOGY | 1999年 / 26卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：399 / 406
页数：8
相关论文
共 124 条
[1]   PEPTIDE-HORMONEACTIVE AND SEROTONIN-IMMUNOREACTIVE TUMOR-CELLS IN CARCINOMA OF THE PROSTATE [J].
ABRAHAMSSON, PA ;
WADSTROM, LB ;
ALUMETS, J ;
FALKMER, S ;
GRIMELIUS, L .
PATHOLOGY RESEARCH AND PRACTICE, 1987, 182 (03) :298-307
[2]   THE COURSE OF NEURO-ENDOCRINE DIFFERENTIATION IN PROSTATIC CARCINOMAS - AN IMMUNOHISTOCHEMICAL STUDY TESTING CHROMOGRANIN-A AS AN ENDOCRINE MARKER [J].
ABRAHAMSSON, PA ;
FALKMER, S ;
FALT, K ;
GRIMELIUS, L .
PATHOLOGY RESEARCH AND PRACTICE, 1989, 185 (03) :373-380
[3]   PANETH CELL-LIKE CHANGE IN PROSTATIC ADENOCARCINOMA REPRESENTS NEUROENDOCRINE DIFFERENTIATION - REPORT OF 30 CASES [J].
ADLAKHA, H ;
BOSTWICK, DG .
HUMAN PATHOLOGY, 1994, 25 (02) :135-139
[4]   ARE NEUROENDOCRINE CELLS OF PRACTICAL VALUE AS AN INDEPENDENT PROGNOSTIC PARAMETER IN PROSTATE-CANCER [J].
ALLEN, FJ ;
VANVELDEN, DJJ ;
HEYNS, CF .
BRITISH JOURNAL OF UROLOGY, 1995, 75 (06) :751-754
[5]  
Angelsen A, 1997, PROSTATE, V31, P110, DOI 10.1002/(SICI)1097-0045(19970501)31:2<110::AID-PROS6>3.0.CO
[6]  
2-R
[7]  
Angelsen A, 1997, PROSTATE, V30, P1
[8]   bcl-2 Overexpression combined with p53 protein accumulation correlates with hormone-refractory prostate cancer [J].
Apakama, I ;
Robinson, MC ;
Walter, NM ;
Charlton, RG ;
Royds, JA ;
Fuller, CE ;
Neal, DE ;
Hamdy, FC .
BRITISH JOURNAL OF CANCER, 1996, 74 (08) :1258-1262
[9]  
APRIKIAN AG, 1993, CANCER, V71, P3952, DOI 10.1002/1097-0142(19930615)71:12<3952::AID-CNCR2820711226>3.0.CO
[10]  
2-X
12345678910